PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Nov-2023 MedX Announces the Appointment of Jeffrey Morris as VP of Sales and Marketing Businesswire
02-Nov-2023 Aptar Named Among Top 15 of the ‘World’s Top Companies for Women 2023’ by Forbes Businesswire
01-Nov-2023 NUBURU Appoints Brian Knaley as new CEO Businesswire
01-Nov-2023 Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress Businesswire
01-Nov-2023 Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology Businesswire
01-Nov-2023 Glaukos Announces Third Quarter 2023 Financial Results Businesswire
01-Nov-2023 Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update Businesswire
01-Nov-2023 Electromed, Inc. Announces Hospital Market Release SmartVest Clearway, Fifth Generation HFCWO Airway Clearance Generator Businesswire
01-Nov-2023 Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea Businesswire
01-Nov-2023 Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results Businesswire
01-Nov-2023 Proteomics Reagents Dominate Market, While Drug Discovery Applications Exhibit Highest Growth Rate - ResearchAndMarkets.com Businesswire
01-Nov-2023 Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023 Fresenius Medical Care AG & Co. KGaA
01-Nov-2023 Miller Barondess Expands IP Litigation Practice Businesswire
01-Nov-2023 Energous Corporation Announces Conference Call for Third Quarter 2023 Financial Results Businesswire
01-Nov-2023 Finalists Named for 2023 ISG Paragon Awards™ South America Businesswire
01-Nov-2023 epocrates Inaugural Healthcare Media Leadership Summit Explores the Future of Healthcare Marketing Businesswire
01-Nov-2023 The Committee to Restore Nymox Shareholder Value Reminds All Nymox Pharmaceutical Shareholders to Take Action and Demand Accountability at Upcoming November 8th Special Meeting Businesswire
01-Nov-2023 Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance Across Pharmaceuticals, Medical Devices, Biologics, and Tobacco Products - ResearchAndMarkets.com Businesswire
01-Nov-2023 Innovative Technologies Fuel Growth in the Global Rare Biomarkers Specimen Collection and Stabilization Market, With Key Players Focusing on Advanced Products - ResearchAndMarkets.com Businesswire
01-Nov-2023 Proteinase K Industry Poised for Growth, with a Valuation of US$ 43.9 Million Expected by 2033, at a CAGR of 4.8% MARKITWIRED